Immunogenicity and safety of a dengue vaccine given as a booster in Singapore: a randomized Phase II, placebo-controlled trial evaluating its effects 5-6 years after completion of the primary series-论文-万方医学网

首页> > Immunogenicity and safety of a dengue vaccine given as a booster in Singapore: a randomized Phase II, placebo-controlled trial evaluating its effects 5-6 years after completion of the primary series

Immunogenicity and safety of a dengue vaccine given as a booster in Singapore: a randomized Phase II, placebo-controlled trial evaluating its effects 5-6 years after completion of the primary series

导出原文传递

翻译打印收藏纠错

第一作者： Park, Juliana

作者： Park, Juliana ^[1] ; Archuleta, Sophia ^[2] ; Oh, May-Lin Helen ^[3] ; Shek, Lynette Pei-Chi ^[4] ; Jin, Jing ^[5] ; Bonaparte, Matthew ^[6] ; Fargo, Carina ; Bouckenooghe, Alain

作者单位： Sanofi Pasteur,Sanofi Pasteur, Clin Res & Dev, Singapore, Singapore ^[1] Univ Med Cluster,Univ Med Cluster, Natl Univ Hosp, Div Infect Dis, Singapore, Singapore ^[2] Changi Gen Hosp,Changi Gen Hosp, Dept Med, Singapore, Singapore ^[3] Natl Univ Singapore,Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Pediat, Singapore, Singapore ^[4] Sanofi,Sanofi, Biostat, Beijing, Peoples R China ^[5] Sanofi Pasteur,Sanofi Pasteur, Global Clin Immunol Dept, Swiftwater, PA USA ^[6]

关键词 CYD-TDV dengue Singapore booster vaccine tetravalent RECOMBINANT

发布时间 2022-05-28

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览0

相似文献

中文期刊
外文期刊
学位论文
会议论文

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

法律状态公告日	法律状态	法律状态信息

检索历史清除

Immunogenicity and safety of a dengue vaccine given as a booster in Singapore: a randomized Phase II, placebo-controlled trial evaluating its effects 5-6 years after completion of the primary series

相似文献

同项目论文

相关期刊

检索历史 清除

Immunogenicity and safety of a dengue vaccine given as a booster in Singapore: a randomized Phase II, placebo-controlled trial evaluating its effects 5-6 years after completion of the primary series

相似文献

同项目论文

相关期刊

检索历史清除